TITLE:
Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension

CONDITION:
Glaucoma

INTERVENTION:
BETAXON (levobetaxolol HCl)

SUMMARY:

      The purpose of this study is to evaluate the safety and efficacy of both BETAXON and AZOPT
      in pediatric patients. Patients will dose with study drug at 8 am and 8 pm daily for twelve
      weeks. Patients will have vision tested, slit lamp exam, blood pressure and pulse checks at
      each visit. Patients will have a dilated fundus exam and corneal measurements taken at first
      and last visit.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: N/A to 5 Years
Criteria:

        INCLUSION:

          -  Children 5 years old and younger

          -  require treatment for glaucoma or ocular hypertension

          -  vision is 20/80 or better

          -  cup-to-disc ratio of 0.8 or less

        EXCLUSION:

          -  do not have abnormal fixation

          -  IOP greater than 36 mm Hg

          -  significant retinal disease

          -  penetrating keratoplasty

          -  severe ocular pathology

          -  optic atrophy

          -  eye surgery in the past 30 days

          -  cardiovascular abnormalities

          -  hypersensitivity to beta blockers, carbonic anhydrase inhibitors or sulfa drugs
      
